Longevity medicine is an emerging, contested field—not a universally established medical specialty. Its credibility depends on whether a clinic’s specific claims are supported by human evidence, meaningful health outcomes, transparent safety practices and the rules of the jurisdiction where it operates. For consumers, that also means knowing what a proposed test or treatment can—and cannot—show before paying for it.
What “longevity medicine” can mean
The term covers different activities: prevention and management of age-related health risks, research into biological processes associated with aging, biomarker-led assessment, and commercial services marketed as “anti-aging.” These are not interchangeable. Evidence for a research program does not establish that every test, supplement, drug or clinic service sold under the longevity label is effective.
Geroscience investigates how aging-related mechanisms might contribute to multiple age-related conditions and whether those conditions could be prevented or delayed. Translating that research into clinical care requires separate evidence for each intervention and claim. In a December 2025 ethics analysis, the AMA Journal of Ethics noted that no gerotherapeutics had been approved for “anti-aging” purposes in humans as of its publication. That is a date-specific statement about that purpose, not a claim that no medicines are approved to treat particular diseases associated with age.
What makes an age-related condition a useful clinical category?
An international consensus statement proposed three criteria for classifying an age-related pathology, disease or syndrome. The condition should:
PC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minute#1 Best Overall
- Develop or progress as chronological age increases.
- Be associated with, or contribute to, functional decline or greater susceptibility to it.
- Be supported by evidence from human studies.
The criteria were approved through an expert consensus process after a meeting of 150 recognized experts in Cardiff on February 19, 2024; the statement required at least 70% agreement for each proposed criterion. Published online on September 21, 2024, and in the April 2025 issue of GeroScience, the ICCARP consensus statement helps define which conditions may be considered age-related. It does not establish that aging itself is a disease or that a particular intervention reverses aging.
How to judge a treatment claim
A credible clinical claim should identify who the treatment is for, what intervention is proposed, what human evidence supports it, which outcome matters to patients, and how risks and follow-up will be handled. A change in a laboratory result is not automatically evidence of improved health.
Rank #2
When assessing a clinic or therapy, ask:
- What outcome is the treatment intended to improve? Look for evidence about a defined disease, function or another outcome that matters to patients—not just a claim that a number or score changed.
- Who was studied? Check whether human studies included people like the intended patient and whether they evaluated the same intervention being offered.
- What is known about safety? Ask about potential risks, monitoring, follow-up and what happens if a problem arises.
- What will the service cost, and what is included? Before agreeing to a clinic package, request an itemized estimate and ask which results could change care. A test or treatment’s price does not establish its clinical value.
- Who is accountable for the care? Ask who interprets results, what qualifications they hold, and how recommendations will be coordinated with other clinicians.
The AMA ethics analysis recommends judging proposed longevity drugs by outcomes such as delaying particular age-related diseases or improving functional health, rather than by a biomarker change alone. It also frames responsible translation around clinical utility, safety, individual values, equity and prevention of age-related conditions.
What a biological-age test can—and cannot—tell you
A biological-age score should not be treated as a direct measure of remaining lifespan or proof that a treatment extended healthspan. A consensus statement on biomarkers for intervention studies identifies qualities that matter when evaluating a measure: it should be relevant to aging, reliably and objectively measured, predictive of functional or biological aspects of aging, responsive to interventions, feasible for clinical use, and sufficiently sensitive and specific. It should also be possible to monitor aging separately from disease processes.
The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Those are evaluation criteria, not a blanket endorsement of commercial tests. A score may be scientifically interesting without being a validated substitute for a patient-relevant outcome. The expert consensus on biomarkers of aging, published online December 21, 2024, addresses biomarkers for intervention studies; it does not establish that any particular commercial test meets the criteria.
A practical comparison before choosing a clinic or service
| What to assess | Questions to ask | Why it matters |
|---|---|---|
| Human evidence | Have the relevant effects been shown in human studies, and in what population? | Evidence about an age-related mechanism or condition does not by itself establish that a specific service works. The ICCARP criteria rely on human studies when classifying age-related conditions. |
| Patient-relevant outcome | Does the evidence concern disease, function or another meaningful health outcome, or only a biomarker? | A change in a biomarker alone does not show that a patient’s health improved. |
| Biomarker quality | Is the measure reliable, relevant to aging, predictive, responsive and suitable for clinical use? | These are among the qualities identified in the expert consensus on biomarkers of aging. |
| Safety and monitoring | What risks, follow-up and monitoring are described? | Clinical utility and safety are part of responsible integration into care. |
| Regulatory setting | Which jurisdiction’s rules apply to this provider and service? | Licensing requirements differ by place; one country’s rules should not be assumed to apply elsewhere. |
| Professional accountability | Are clinicians’ qualifications, applicable guidelines and standards clear? | Professional activity in the field does not, on its own, establish formal specialty recognition. |
What regulation looks like in Singapore—and why location matters
In a notice dated May 5, 2026, Singapore’s Ministry of Health said outpatient medical service providers, including those offering longevity-related services, must be licensed and comply with the Healthcare Services Act. The ministry also said the Act and the Singapore Medical Council’s Ethical Code and Ethical Guidelines require safe, rational and evidence-based treatment in accordance with accepted clinical practice. See the Singapore Ministry of Health notice for that jurisdiction’s position. It should not be read as a description of rules in other countries.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Professional growth is not the same as specialty recognition
Professional organizations and forums can help develop education, research, recommendations and clinical standards. The Healthy Longevity Medicine Society describes aims that include education, research, professional development and coordination across areas of longevity medicine. A 2025 international roundtable on longevity clinics discusses work toward best-practice guidelines and standards while noting that comprehensive assessment and clinical readiness remain areas for further work.
These activities show that the field is organizing; they do not establish that national accrediting bodies universally recognize longevity medicine as a medical specialty. Patients should therefore check the individual clinician’s qualifications and the standards that actually apply to the service they are considering.
Do these 3 things before closing this tab:
1Scan for outdated or missing drivers - takes under a minute2Clear out junk files and repair common Windows errors3Fix the driver behind crashes, sound loss and screen glitchesQuick Recap
Best Value
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
